Helaleh Khoshbakht

Dr. Helaleh Khoshbakht is a highly respected radiation oncologist in Tehran with extensive expertise in treating various cancers, including breast, esophageal, rectal, gastric, intestinal, uterine, cervical, sarcoma, and head and neck cancers. She earned her specialized degree in radiotherapy oncology from Shahid Beheshti University of Medical Sciences and later joined Iran University of Medical Sciences as a faculty member, where she contributes to education, research, and advancements in oncology.

Commitment to Research & Innovation

Dr. Khoshbakht actively participates in international congresses and has published numerous articles in leading medical journals. Her research focuses on critical areas such as:

The impact of chemotherapy on cancer treatment outcomes
Evaluating the effectiveness of different treatment regimens
Exploring the connection between breast cancer and thyroid disorders

Advancing Cancer Care Through Technology & Education

With a strong dedication to integrating the latest health technologies and cancer treatment advancements, Dr. Khoshbakht plays a key role in research projects and educational initiatives. Her work not only enhances patient care but also provides hope and cutting-edge treatment options for those battling cancer.

Dr. Khoshbakht’s passion for oncology drives her to make meaningful contributions to the field, ensuring patients receive the most advanced and compassionate care possible.

Gallery

Education

Doctor of Medicine (M.D.)
Specialty in Radiation Oncology: Shahid Beheshti University of Medical Sciences

Languages

English
Persian

Memberships & Certifications

Member of the Iran Medical Council: License Number 102950
Member of the Iranian Society of Radiation (Clinical) Oncology

Morning

Monday:
Tuseday:
Wednesday:
Thursday:
Friday:
Saturday:
Sunday:
–
–
–
–
–
–
–

Evening

Monday:
Tuseday:
Wednesday:
Thursday:
Friday:
Saturday:
Sunday:
–
–
–
–
–
–
–

1. What is the newest method of cancer treatment, including T-cell therapy and combined immunotherapy?

T-cell therapy and combined immunotherapy are advanced treatments that harness the body’s immune system to target and destroy cancer cells. These therapies modify T-cells to better recognize and attack cancerous cells, offering a promising approach to treating certain types of cancer.

2. What are the classical methods for cancer treatment?

Classical cancer treatments include surgery, chemotherapy, and radiotherapy. These methods target cancer by removing tumors, using drugs to kill cancer cells, or applying radiation to destroy malignant cells.

3. Does using the latest cancer treatment methods guarantee definitive results?

While advanced methods like immunotherapy and targeted therapies show great promise, they may not guarantee definitive results for all patients. Outcomes vary based on the type of cancer, its stage, and individual patient factors.

4. How does the human immune system fight cancer?

The immune system identifies and attacks abnormal cells, including cancer cells. However, cancer cells can sometimes evade detection. Immunotherapy helps boost or modify the immune response to better fight cancer.

5. Is immunotherapy useful for grade 4 cancer?

Immunotherapy can be useful in treating stage 4 (advanced) cancers, but its effectiveness depends on the type of cancer. In some cases, immunotherapy may help prolong survival or improve quality of life.

6. Can immunotherapy and advanced radiotherapy be combined for better results?

Yes, combining immunotherapy with advanced radiotherapy can sometimes lead to better outcomes. Radiotherapy can help to weaken cancer cells, making them more vulnerable to immune system attacks when combined with immunotherapy.

7. What role does advanced radiotherapy play in cancer treatment?

Advanced radiotherapy methods, such as SRS, SBRT, and VMAT, allow for more precise targeting of tumors, minimizing damage to healthy tissues. These methods help treat hard-to-reach tumors and improve overall cancer treatment outcomes.

8. What are the most important types of radiotherapy?

Key types of radiotherapy include External Beam Radiation Therapy (EBRT), Stereotactic Radiosurgery (SRS), Stereotactic Body Radiotherapy (SBRT), and Brachytherapy. Each type is used depending on the cancer location and treatment goals.

9. Does radiation therapy hurt, and what are the complications of radiotherapy?

Radiation therapy itself is painless, but it may cause side effects such as skin irritation, fatigue, and, in some cases, nausea. Long-term complications can include damage to nearby tissues, depending on the area treated.

10. What is the difference between metastasis and metastatic cancer?

Metastasis refers to the spread of cancer from its original site to other parts of the body. Metastatic cancer is the term used when cancer has already spread to distant organs or tissues.

11. What are brain tumors, and what is the newest treatment for brain tumors?

Brain tumors can be either benign or malignant. New treatments for brain tumors include advanced radiotherapy techniques like SRS and SBRT, which allow precise targeting of the tumor with minimal damage to surrounding tissues.

12. What is the success rate of radiation therapy and advanced radiotherapy in cancer treatment?

The success rate of radiation therapy varies by cancer type and stage. Advanced radiotherapy techniques, such as VMAT and SBRT, often have higher success rates due to their precision and ability to deliver higher doses to tumors while sparing healthy tissues.

13. What is the newest SRS, SBRT, and VMAT radiotherapy method?

SRS (Stereotactic Radiosurgery), SBRT (Stereotactic Body Radiotherapy), and VMAT (Volumetric Modulated Arc Therapy) are cutting-edge radiotherapy techniques that provide precise, high-dose radiation to tumors, often in fewer sessions, improving treatment effectiveness and reducing side effects.

14. What is the definitive treatment for lymphoma cancer?

There is no one-size-fits-all treatment for lymphoma. However, treatments such as chemotherapy, immunotherapy, and radiotherapy are commonly used. For Hodgkin’s and non-Hodgkin’s lymphoma, treatment may involve a combination of these therapies depending on the stage and type.

15. How are Hodgkin's and non-Hodgkin's lymphoma treated?

Hodgkin's lymphoma is often treated with chemotherapy, radiation, and sometimes immunotherapy. Non-Hodgkin's lymphoma treatment depends on its type and can include chemotherapy, immunotherapy, and targeted therapies.